Lawrence A Kenyon - Net Worth and Insider Trading
Lawrence A Kenyon Net Worth
The estimated net worth of Lawrence A Kenyon is at least $10,108 dollars as of 2024-12-27. Lawrence A Kenyon is the CFO of Outlook Therapeutics Inc and owns about 5,946 shares of Outlook Therapeutics Inc (OTLK) stock worth over $10,108. Details can be seen in Lawrence A Kenyon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lawrence A Kenyon has not made any transactions after 2024-09-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lawrence A Kenyon
Lawrence A Kenyon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lawrence A Kenyon owns 2 companies in total, including Outlook Therapeutics Inc (OTLK) , and Arno Therapeutics Inc (ARNI) .
Click here to see the complete history of Lawrence A Kenyon’s form 4 insider trades.
Insider Ownership Summary of Lawrence A Kenyon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2024-09-26 | CFO and Secretary |
| ARNI | Arno Therapeutics Inc | 2014-02-24 | Chief Financial Officer |
Lawrence A Kenyon Latest Holdings Summary
Lawrence A Kenyon currently owns a total of 1 stock. Lawrence A Kenyon owns 5,946 shares of Outlook Therapeutics Inc (OTLK) as of September 26, 2024, with a value of $10,108.
Latest Holdings of Lawrence A Kenyon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2024-09-26 | 5,946 | 1.70 | 10,108 |
Holding Weightings of Lawrence A Kenyon
Lawrence A Kenyon Form 4 Trading Tracker
According to the SEC Form 4 filings, Lawrence A Kenyon has made a total of 2 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Outlook Therapeutics Inc is the acquisition of 5,000 shares on September 26, 2024, which cost Lawrence A Kenyon around $28,450.
Insider Trading History of Lawrence A Kenyon
- 1
Lawrence A Kenyon Trading Performance
GuruFocus tracks the stock performance after each of Lawrence A Kenyon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lawrence A Kenyon is -41.5%. GuruFocus also compares Lawrence A Kenyon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lawrence A Kenyon within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lawrence A Kenyon's insider trading performs compared to the benchmark.
Performance of Lawrence A Kenyon
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.78 | | | | | |
| Relative Return to S&P 500(%) | 9.7 | | | | | |
Lawrence A Kenyon Ownership Network
Lawrence A Kenyon Owned Company Details
What does Outlook Therapeutics Inc do?
Who are the key executives at Outlook Therapeutics Inc?
Lawrence A Kenyon is the CFO and Secretary of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include Chief Commercial Officer Jeff Evanson , Chief Operating Officer Terry Dagnon , and director & CEO and President Trenary C Russell Iii .
Outlook Therapeutics Inc (OTLK) Insider Trades Summary
Over the past 18 months, Lawrence A Kenyon made 1 insider transaction in Outlook Therapeutics Inc (OTLK) with a net purchase of 5,000. Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net purchase of 62,484 shares made by Jeff Evanson , a net purchase of 1,882 shares made by Yezan Munther Haddadin ,
In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Outlook Therapeutics Inc (OTLK) were sold and 10,006 shares were bought by its insiders, resulting in a net purchase of 10,006 shares.
Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Outlook Therapeutics Inc Insider Transactions
Lawrence A Kenyon Mailing Address
Above is the net worth, insider trading, and ownership report for Lawrence A Kenyon. You might contact Lawrence A Kenyon via mailing address: C/o Outlook Therapeutics, Inc., 7 Clarke Drive, Cranbury Nj 08512.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
